Access cutting-edge hemophilia b treatment through this clinical trial at a research site in Gainesville. Study-provided care at no cost to qualified participants.
Access hemophilia b specialists in Gainesville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemophilia b treatment provided free
This is a phase 3, prospective, open-label, single-arm, single-dose, multicenter study investigating the efficacy, safety, and tolerability of CSL222 (AAV5-hFIXco-Padua) in adolescent male participants with severe or moderately severe hemophilia B.
Sponsor: CSL Behring
Check if you qualify for this hemophilia b clinical trial in Gainesville, FL
If you're searching for hemophilia b treatment options in Gainesville, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gainesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemophilia b specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.